Evolent Health, Inc.
EVH · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,290,173 | $3,674,621 | $2,631,068 | $2,381,474 |
| - Cash | $104,203 | $192,825 | $188,200 | $266,280 |
| + Debt | $713,673 | $644,796 | $476,118 | $280,467 |
| Enterprise Value | $1,899,643 | $4,126,592 | $2,918,986 | $2,395,661 |
| Revenue | $2,554,741 | $1,963,896 | $1,352,013 | $907,957 |
| % Growth | 30.1% | 45.3% | 48.9% | – |
| Gross Profit | $367,353 | $460,470 | $316,584 | $250,406 |
| % Margin | 14.4% | 23.4% | 23.4% | 27.6% |
| EBITDA | $84,854 | -$24,785 | $43,746 | $55,661 |
| % Margin | 3.3% | -1.3% | 3.2% | 6.1% |
| Net Income | -$61,623 | -$113,040 | -$19,164 | -$37,601 |
| % Margin | -2.4% | -5.8% | -1.4% | -4.1% |
| EPS Diluted | -0.81 | -1.28 | -0.2 | -0.36 |
| % Growth | 36.7% | -540% | 44.4% | – |
| Operating Cash Flow | $18,765 | $142,582 | -$11,553 | $38,747 |
| Capital Expenditures | -$24,893 | -$28,745 | -$38,361 | -$24,983 |
| Free Cash Flow | -$6,128 | $113,837 | -$49,914 | $13,764 |